Order Article Reprints

Moreau M, Carmona-Iragui M, Altuna M, Dalzon L, Barroeta I, Vilaire M, Durand S, Fortea J, Rebillat A-S, Janel N. DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients. Biomedicines. 2022; 10(6):1380. https://doi.org/10.3390/biomedicines10061380

Moreau, Manon, Maria Carmona-Iragui, Miren Altuna, Lorraine Dalzon, Isabel Barroeta, Marie Vilaire, Sophie Durand, Juan Fortea, Anne-Sophie Rebillat, and Nathalie Janel. 2022. "DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients" Biomedicines 10, no. 6: 1380. https://doi.org/10.3390/biomedicines10061380

Moreau, M., Carmona-Iragui, M., Altuna, M., Dalzon, L., Barroeta, I., Vilaire, M., Durand, S., Fortea, J., Rebillat, A.-S., & Janel, N. (2022). DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients. Biomedicines, 10(6), 1380. https://doi.org/10.3390/biomedicines10061380